Imagin Medical Inc

DPD3

Company Profile

  • Business description

    Imagin Medical Inc is a Urologic Oncology company developing technologies to visualize and treat urologic cancers, including bladder and prostate cancer, through minimally invasive surgery. The company’s first product, the i/Blue Imaging System, with its proprietary optics and light sensors, will greatly increase the efficiency and accuracy of detecting bladder cancer, helping to improve the surgical management of this disease. Imagin's follow-on product, the enCAGE Coil is a device with 510(k) clearance for soft tissue ablation. Imagin intends to refine the disposable bipolar radio frequency-based probe for use in the treatment of prostate cancer and benign prostate hypoplasia (BPH) and submit appropriate FDA premarket applications for the new indications.

  • Contact

    890 West Pender Street
    Suite 600
    VancouverBCV6C 1J9
    CAN

    T: +1 833 246-2446

    E: [email protected]

    https://www.imaginmedical.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Medical Devices

    Fiscal Year End

    30 September 2026

    Employees

Stocks News & Analysis

stocks

Continuing problems at the ASX

Interim report by financial regulator is a hit to sentiment.
stocks

Top investing lessons from 2025

13 lessons from Morningstar’s James Gruber.
stocks

Chart of the Week: Aussie dividend yields are less attractive than alternatives

The latest insights from our equity research team.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,875.7032.600.37%
CAC 408,086.0520.11-0.25%
DAX 4023,960.59116.28-0.48%
Dow JONES (US)47,885.97228.29-0.47%
FTSE 1009,774.3289.530.92%
HKSE25,355.36113.42-0.45%
NASDAQ22,693.32418.14-1.81%
Nikkei 22549,059.91452.37-0.91%
NZX 50 Index13,256.7739.14-0.29%
S&P 5006,721.4378.83-1.16%
S&P/ASX 2008,588.2031.700.37%
SSE Composite Index3,878.027.740.20%

Market Movers